DexCom (NASDAQ:DXCM – Free Report) had its target price increased by Piper Sandler from $135.00 to $150.00 in a research report report published on Tuesday morning, Benzinga reports. The brokerage currently has an overweight rating on the medical device company’s stock. Other equities analysts have also recently issued research reports about the company. Stifel Nicolaus […]
Granite Bay Wealth Management LLC Buys New Stake in DexCom, Inc (NASDAQ:DXCM) themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.
Tracking Ron Baron s BAMCO Portfolio – Q3 2023 Update (MUTF:BARIX) seekingalpha.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from seekingalpha.com Daily Mail and Mail on Sunday newspapers.
/PRNewswire/ The "Worldwide Market for In Vitro Diagnostic Tests, 16th Edition" report has been added to ResearchAndMarkets.com s offering. The 16th edition.